![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
STaR: Virologic Outcomes and Safety in ART-Naïve Adult Females for Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF Compared to Efavirenz/Emtricitabine/Tenofovir DF at Week 48
|
|
|
Reported by Jules Levin
53rd Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC)September 10-13, 2013
Denver, CO, USA
C Brinson1, S Segal-Maurer2, I Brar3, C Creticos4, C McDonald5, B Wade6, R Ebrahimi7, D Porter7, S De-Oertel7, T Fralich7, J DeMorin7, K Khorana7
1Central Texas Clinical Research, Austin, TX, USA; 2New York Hospital Queens, Flushing, NY, USA; 3Henry Ford Hospital, Detroit, MI, USA; 4NorthShore University Health System, Chicago, IL, USA; 5Tarrant County Infectious Disease, Fort Worth, TX, USA; 6Center for Prevention/Treatment, Pensacola, FL, USA; 7Gilead Sciences, Foster City, CA, USA
![ICAAC1.gif](../images/091613/091613-9/ICAAC1.gif)
![ICAAC2.gif](../images/091613/091613-9/ICAAC2.gif)
![ICAAC3.gif](../images/091613/091613-9/ICAAC3.gif)
![ICAAC4.gif](../images/091613/091613-9/ICAAC4.gif)
![ICAAC5.gif](../images/091613/091613-9/ICAAC5.gif)
![ICAAC6.gif](../images/091613/091613-9/ICAAC6.gif)
![ICAAC7.gif](../images/091613/091613-9/ICAAC7.gif)
![ICAAC8.gif](../images/091613/091613-9/ICAAC8.gif)
![ICAAC9.gif](../images/091613/091613-9/ICAAC9.gif)
![ICAAC10.gif](../images/091613/091613-9/ICAAC10.gif)
![ICAAC11.gif](../images/091613/091613-9/ICAAC11.gif)
![ICAAC12.gif](../images/091613/091613-9/ICAAC12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|